|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-8-29
|
|
pubmed:abstractText |
The development and growth of human prostate cancer is mediated by many tumor cell-derived growth factors. Heparin affin regulatory peptide (HARP) seems to be involved in the progression of several tumors of diverse origin. In the present study, we sought to determine if HARP is implicated in human prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2005 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
151-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15924335-Carrier Proteins,
pubmed-meshheading:15924335-Cell Adhesion,
pubmed-meshheading:15924335-Cell Movement,
pubmed-meshheading:15924335-Cell Proliferation,
pubmed-meshheading:15924335-Cytokines,
pubmed-meshheading:15924335-Gene Expression Profiling,
pubmed-meshheading:15924335-Humans,
pubmed-meshheading:15924335-Male,
pubmed-meshheading:15924335-Neovascularization, Pathologic,
pubmed-meshheading:15924335-Prostatic Neoplasms,
pubmed-meshheading:15924335-Tumor Cells, Cultured
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity.
|
|
pubmed:affiliation |
Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Greece.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
